Cargando…
Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
The spread of SARS-CoV-2 and the increasing mortality rates of COVID-19 create an urgent need for treatments, which are currently lacking. Although vaccines have been approved by the FDA for emergency use in the U.S., patients will continue to require pharmacologic intervention to reduce morbidity a...
Autores principales: | Policard, Martine, Jain, Sidharth, Rego, Samantha, Dakshanamurthy, Sivanesan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163696/ https://www.ncbi.nlm.nih.gov/pubmed/34058265 http://dx.doi.org/10.1016/j.virusres.2021.198464 |
Ejemplares similares
-
Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
por: Policard, Martine, et al.
Publicado: (2021) -
RNASeq profiling of COVID19‐infected patients identified an EIF2AK2 inhibitor as a potent SARS‐CoV‐2 antiviral
por: Jain, Sidharth, et al.
Publicado: (2022) -
SARS-CoV2 Infection and Comorbidities, Role in Oncogenesis
por: Spirina, Liudmila V, et al.
Publicado: (2022) -
SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein
por: Parn, Simone, et al.
Publicado: (2022) -
Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)